Found 75 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 3
Interventional
This study investigates how effective an investigational medication is for treating chronic lung allograft dysfunction (CLAD) in adults.The study focuses on evaluating the safety and effectiveness of the investigational medication when used alongside standard treatments. It aims to understand if this approach can improve lung function in people with CLAD.Who …
18 years or above
All genders
Phase 3
Interventional
This study investigates the condition known as chronic rhinosinusitis with nasal polyps (CRSwNP). The purpose is to understand how an investigational medication may work in individuals who have not seen improvement with standard treatments. Participants will continue using their usual intranasal corticosteroids while taking part in this research.The study aims …
18 years or above
All genders
Phase 3
Interventional
This study investigates the condition of chronic rhinosinusitis with nasal polyps (CRSwNP) to assess the effectiveness and safety of adding an investigational medication to current treatments.The study focuses on evaluating how well the investigational medication works and its safety when used with standard nasal treatments. Researchers aim to understand its …
All genders
Phase 2
Interventional
This study investigates the long-term safety and effectiveness of an investigational medication in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). The study focuses on evaluating how well the investigational medication works over a longer period and how safe it is for participants. The aim is to understand more about …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with ulcerative colitis. The aim is to understand how the medication works for people with moderate to severe cases of this condition.Researchers are focusing on evaluating the safety and effectiveness of different doses of the investigational medication. The study …
18 years or above
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on people with moderate to severe hidradenitis suppurativa. The study aims to understand how the medication works in managing this condition.The focus of the study is to evaluate the safety and effectiveness of the investigational medication for people with hidradenitis suppurativa. …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication in people with moderately to severely active Ulcerative Colitis (UC).The purpose of this study is to evaluate the safety and effectiveness of the investigational medication in managing symptoms of Ulcerative Colitis. Researchers aim to understand how well the medication works and …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on people with moderately to severely active ulcerative colitis.The focus of the study is to assess how safe and effective the investigational medication is for treating the symptoms of ulcerative colitis over time.Who can participate: Participants aged 16 to 80 years …
18 years or above
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with moderate to severe hidradenitis suppurativa. The purpose is to understand how well the medication works and how safe it is for people with this condition.The study focuses on evaluating the overall safety and effectiveness of the investigational medication …
6 months - 17 years
All genders
Phase 3
Interventional
This study investigates the pharmacokinetics and safety of an investigational medication in children aged 6 months to under 18 years with prurigo nodularis. The purpose of the study is to understand how the investigational medication is processed in the body and to assess its safety for the participants.Participants in the …